You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Overview

Priorix is indicated for the active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella. [1]
For use in children between 9 to 12 months of age please refer to the Summary of Product Characteristics (SPC). [1]

References:

  1. Priorix Summary of Product Characteristics. Available from: http://www.medicines.ie/medicine/6879/SPC/Priorix+PFS/ Last accessed - January 2017

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Priorix is a registered trademark of the GlaxoSmithKline group of companies